Clinical Care

Using newborns’ own umbilical cords as shunts for heart surgery

Cardiac surgery is reducing the use of plastic — starting with an operation for newborns who have life-threatening heart disease generally called single ventricle. Single ventricle is so dangerous because it means only one of the heart’s two ventricles can adequately pump blood. Typically, affected infants undergo open-heart surgery to receive a Blalock shunt, which ... Read More about Using newborns’ own umbilical cords as shunts for heart surgery
Research
The CRISPR system at work

A first for CRISPR: Cutting genes in blood stem cells

CRISPR — a gene editing technology that lets researchers make precise mutations, deletions and even replacements in genomic DNA — is all the rage among genomic researchers right now. First discovered as a kind of genomic immune memory in bacteria, labs around the world are trying to leverage the technology for diseases ranging from malaria ... Read More about A first for CRISPR: Cutting genes in blood stem cells
Research
medulloblastoma in a child

Beyond appearances: Molecular genetics revises brain tumor classification and care

Pomeroy Scott Pomeroy, MD, PhD, is Neurologist-in-Chief at Boston Children’s Hospital. He practices in the Brain Tumor Center and is a member of the F.M. Kirby Neurobiology Center. For almost a century, brain tumors have been diagnosed based on their appearance under a microscope and classified by their resemblance to the brain cells from which ... Read More about Beyond appearances: Molecular genetics revises brain tumor classification and care
Research
Emily Coughlin during her neuroblastoma treatment

Double stem cell transplant and other tools are helping children survive neuroblastoma

When Emily Coughlin complained of a sore knee in May 2009, doctors initially suspected Lyme disease. After antibiotics failed to relieve the pain, Emily was diagnosed with neuroblastoma, a cancer that begins in nerve cells outside the brain, just shy of her fourth birthday. Though neuroblastomia is rare — about 700 new cases occur annually in the ... Read More about Double stem cell transplant and other tools are helping children survive neuroblastoma
Patient Stories

Wine used to toast CGD gene therapy trial linked to decades-long scientific journey

When Brenden Whittaker of Columbus, Ohio, the first patient treated with gene therapy for chronic granulomatous disease (CGD), showed successful engraftment last winter, the gene therapy team lifted glasses for a celebratory toast. The wine they sipped was no ordinary wine. The 2012 Bordeaux blend came from an award-winning California vineyard owned and operated by Robert ... Read More about Wine used to toast CGD gene therapy trial linked to decades-long scientific journey
Clinical Care

Detecting shunt failure in hydrocephalus without imaging or surgery: ShuntCheck

Antonio Venus-Reeve, 14, had his first shunt surgery for hydrocephalus when he was 2½ months old. Born at 25 weeks’ gestation, weighing less than two pounds, he had a serious brain bleed seven days later. As Antonio’s head began to swell with excess fluid, neurologists at Boston Children’s Hospital told his mother, Joanne Venus-Williams, that ... Read More about Detecting shunt failure in hydrocephalus without imaging or surgery: ShuntCheck
Research
gold nanoparticles pain relief

DIY pain relief with light-activated local nerve blocks

You’ve just had a root canal or knee surgery — both situations that will likely require some sort of local pain medication. But instead of taking a systemic narcotic with all its side effects, what if you could medicate only the part of your body that hurts, only when needed and only as much as ... Read More about DIY pain relief with light-activated local nerve blocks
Clinical Care
microbiome concept

Microbiome therapeutics: 6 takeaways from a MassBio panel

Seeing the surprising success of “poop pills” in gastrointestinal C. difficile infection, pharma companies and startups are embracing the microbiome as a new therapeutic target for an astonishing range of maladies. To learn what pioneering companies in the space are thinking about the hope and the hype, Vector recently attended a panel on microbiome therapeutics ... Read More about Microbiome therapeutics: 6 takeaways from a MassBio panel